In the fight against the novel coronavirus, Bengaluru-based startup BlinkIn helped Wuhan, the sprawling capital of Central China’s Hubei province and the epicentre of the pandemic, with its augmented reality (AR) product, according to a Mint report.
As Wuhan was hit by COVID-19, authorities set up temporary hospitals to specifically cater to the flooding cases of the virus. In these centres, ventilators were vital and many came from a German manufacturer, Huber & Ranner. However, their installation had become difficult as technicians could not go to Wuhan.
In such a situation, BlinkIn, a NASSCOM CoE-incubated startup, helped in the installation of ventilators as Huber & Ranner used its AR product Scotty to provide visual guidance from Pocking in Germany, said the report.
With the use of BlinkIn’s product, hospital staff just had to click on a link to get tech support. All they needed was to point a phone at the ventilator and installation point, and AR markers helped indicate what needed to be done as a technician talked them through the process, the report said.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
Harshwardhan Kumar, CEO and co-founder of BlinkIn, said WebGL lets the user access a mobile phone’s graphics processing unit (GPU) to run computer vision algorithms. “That’s how we bring AR experiences through the Web rather than a mobile app,” Kumar said.
A lightweight product like Scotty is to provide just enough AR for tech support “to get the job done then and there," as per the report.
BlinkIn’s German co-founder and MD Josef Seuss said they just try to understand a problem and create value for customers. Seuss was a consultant to companies in Germany for digital transformation when he first connected with Kumar to do a project for one of his clients. Later, Kumar told him about a smart visual bot they were building, the report stated.
When Seuss saw a lot of interest in the product, he came to Ahmedabad and joined the BlinkIn founders in the accelerator programme and became a co-founder.
The city at the centre of China's virus outbreak reopened for business on March 30 after authorities lifted more of the controls that locked down tens of millions of people for two months. However, it is still under travel controls. Residents are allowed to go to other parts of Hubei but cannot leave the province. Restrictions on other Hubei residents were lifted on March 23. The final curbs on Wuhan will end on April 8.(With inputs from PTI)